Adventris Pharmaceuticals
PrivateLast Round
Seed
Oct 18, 2024
Total Funding Raised
$12.5M
Company Overview
Adventris Pharmaceuticals is a biotechnology company that develops cancer vaccines designed to train the immune system to recognize and attack cancer-causing mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adventris Pharmaceuticals Comparables
Compare Adventris Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elicio Therapeutics | 81% | |
| Circio Holding ASA | 78% | |
| Scancell Holdings Plc | 70% | |
Adventris Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 18, 2024 | ||||
| Pre Seed | Oct 2, 2023 |
Adventris Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Pre Seed |
| Johns Hopkins Technology Ventures | Pre Seed |
| Johns Hopkins Technology Ventures | Pre Seed |
| Y Combinator | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2023
$500K round with Refactor Capital and Y Combinator.
Adventris Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adventris Pharmaceuticals's valuation, stock price, and market status.